February 8, 2012

Symbol:  Markets Quote Level II Charts News Filings Streamer
	OTCBB Company Profile ACCP - ACCESS PHARMACEUTICL Click here to order Full Report   Access Pharmaceuticals, Inc. 2600 Stemmons Freeway Suite 176 Dallas, TX 75207-2107 United States Phone: +1 214 905-5100 Fax: 214-905-5101 http://www.accesspharma.com Jeffrey B. Davis, CEO     SIC Number: 2834 Fiscal Year End: 12-31 Industry: Drugs Transfer Agent: American Stock Transfer & Trust Company CIK: 318306     Market Maker List   Share Data Authorized Outstanding Date Shares Source Date Shares Source 12/31/2005 50,000,000 10-K 08/12/2011 19,410,213 MGFS   Business Summary An emerging pharmaceutical company engaged in the development of novel therapeutics for the treatment of cancer and supportive care of cancer patients.   Symbol Symbol   Name Expiration Date ACCP   Access Pharmaceuticals, Inc. ACCPE   Access Pharmaceuticals, Inc. (Common) 05/26/2009 ACCP   Access Pharmaceuticals, Inc. (Common) 05/21/2009 ACCPE   Access Pharmaceuticals, Inc. (Common) 06/20/2006 ACCP   Access Pharmaceuticals, Inc. (Common) 06/07/2006 AKCA   Access Pharmaceuticals, Inc. 06/05/2006 AKC   Access Pharmaceutical Inc 02/01/2006 AXCS   Access Pharmaceutical Inc 03/30/2000 AXCSD   Access Pharmaceutical Inc New 07/20/1998 AXCS   Access Pharmaceuticals Inc 06/18/1998   Management      Name   Title    Kerry  P  Gray    PR/CEO/DIR    Herbert  H  McDade Jr   CB    Stephen  B  Thompson    CFO/VP/TR    Max  E  Link    DIR    J  Michael  Flinn    DIR    Stephen  B  Howell    DIR    David  P.  Nowotnik    SR VP    Heartland Advisors, Inc.    BO    John  J.  Meakem Jr.   DIR    Larry  N.  Feinberg    BO/XDIR    Oracle Partners, L.P.    BO    Stuart  Duty    DIR    Copyright © 2002. The Nasdaq Stock Market, Inc. Please read our Disclaimer and Privacy Statement. Copyright ©2002 Knobias.com, LLC